Senescence Marker Protein-30 (SMP30) was originally identified as a novel protein in the rat liver, the expression of which decreases androgen-independently with aging. 1,2) SMP30 is a 34 kDa protein expressed mainly in hepatocytes and renal tubular epithelia, 1) and its amino acid sequences are highly conserved among vertebrates, i.e., 70 to 90%, strongly suggesting that the age-dependent decreases of SMP30 reported in the liver, kidney and lung may contribute to senescence.1,3-7) SMP30 transcripts have been detected in multiple mouse tissues including the liver, kidney, brain, lung and testis by reverse transcription-polymerase chain reaction (RT-PCR) analysis. 7) In humans, immunohistochemical staining has localized SMP30 mainly in parenchymal cells of the liver, proximal tubular cells of the kidney, acinal and ductal cells of the pancreas and fasciculata cells of the adrenal cortex.2) The human SMP30 gene, which is located in the p11.3-q11.2 segment of the X chromosome, 4) could be a candidate agent of X-linked diseases mapped to that region.To clarify the physiological functions and the relationships between age-associated decreases of SMP30 and disorders of aged organs, we established SMP30 knockout mice. 8) These knockout animals are viable and fertile but lower in body weight and shorter in life span than the wild-type. 9) Throughout our experiments in vitro and in vivo, the livers of SMP30 knockout mice were far more susceptible to tumor necrosis factor (TNF)-a-and Fas-mediated apoptosis than those from the wild-type. 8) Moreover, histological and biochemical analyses of livers from SMP30 knockout mice showed abnormal accumulations of neutral lipids and phospholipids.9) This abnormal lipid metabolism must increase the tissues' susceptibility to apoptosis. Such changes of SMP30 expression might, then, account for the deterioration of cellular functions and lowered resistance to harmful stimuli in aged tissues.We recently identified SMP30 as a gluconolactonase (GNL, EC 3.1.1.17) that is involved in the vitamin C biosynthetic pathway and found that SMP30/GNL knockout mice cannot synthesize vitamin C in vivo.10) Humans, monkeys and guinea pigs are similarly incapable of synthesizing vitamin C in vivo, because the gluconolactone oxidase gene has mutated throughout evolution; however, mice, rats and many other animals do synthesize vitamin C in vivo. With aging, SMP30/GNL content decreases in the liver, kidney and lung, and such decreases affect the normally copious amount of SMP30/GNL in the livers of younger humans.2) To discern what, if any, functions SMP30/GNL has in the human liver, we transfected the Hep G2 human liver carcinoma cell line with the human SMP30/GNL gene. In the present study, we found that the over-expression of SMP30/GNL in these Hep G2 cells contributed to the decrease of reactive oxygen species (ROS) formation, presumably increasing the cells' state of oxidative stress.
MATERIALS AND METHODSCell Culture Stable transfectants expressing the human SMP30/GNL were established as described p...